Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...

Gallup’s latest health index links the rapid rise of semaglutide and similar injectables to measurable population-level weight loss.

An oral weight loss pill has performed well in clinical trials, positioning it as a potential alternative to injectable GLP-1 medications like Ozempic and Wegovy. The Eli Lilly drug, called ...

Eli Lilly announced that its experimental weight-loss pill, orforglipron, meets most of the criteria for the U.S. Food and ...

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...

A once-a-day pill for obesity could be a cheaper and more accessible weight-loss drug, after a study found the tablet can lead to “significant” reductions in body weight. More than 60 per cent of ...

An oral weight loss pill has performed well in clinical trials, positioning it as a potential alternative to injectable GLP-1 medications like Ozempic and Wegovy. The Eli Lilly drug, called ...

This could really move the needle in the GLP-1 weight loss market. Semaglutide, the active ingredient in Ozempic and Wegovy, is injected into the fatty tissue just under the skin of the stomach, thigh ...

Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global ...

As more Americans turn to GLP-1 medications like Ozempic and Wegovy, restaurants are shrinking portions, reworking menus, and reimagining what a satisfying meal looks like.